PHOSPHO-SODA

Quốc gia: Indonesia

Ngôn ngữ: Tiếng Indonesia

Nguồn: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

Thành phần hoạt chất:

DISODIUM PHOSPHATE DODECAHYDRATE; SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE

Sẵn có từ:

COMBIPHAR - Indonesia

INN (Tên quốc tế):

DISODIUM PHOSPHATE DODECAHYDRATE; SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE

Liều dùng:

24,4 MG ; 10,8 MG

Dạng dược phẩm:

LARUTAN / CAIRAN

Các đơn vị trong gói:

DUS, BOTOL PLASTIK @ 45 ML

Sản xuất bởi:

COMBIPHAR - Indonesia

Ngày ủy quyền:

2019-02-28

Đặc tính sản phẩm

                                COMPOSITION
Each dose (45 mL) contains:
Sodium dihydrogen phosphate dihydrate 24.4 g;
Disodium phosphate dodecahydrate 10.8 g
Also includes: Ethanol, sodium benzoate. Sodium content 5.0 g per each
45 mL dose.
MODE OF ACTION
Phospho-soda produces bowel actions which cleanse the bowel.
Phospho-soda acts by osmotic process to
increase fluid retention in the lumen of the small intestine. Fluid
accumulation in the ileum produces distension
and, in turn, promotes peristalsis and bowel evacuation. It usually
work within 30 minutes, although it may
take as long as six hours.
INDICATIONS
Phospho-soda is used as part of a bowel cleansing procedure before
X-ray of the bowel, colonoscopy
(looking into the bowel with an instrument) or before a bowel
operation.
CONTRAINDICATIONS
Phospho-soda is contraindicated:
• In children under 15 years (particularly at risk of dehidration).
• Patient with faecal impaction, paralytic ileus, bowel obstruction,
hypomotility, Hirschsprung’s disease
(congenital megacolon), imperforate anus, congestive heart failure,
ascites conditions, renal insufficiency
and impaired renal function and pre-existing potential
fluid/electrolyte disturbance.
• Patients at risk of dehydration due to altered senses and/or poor
fluid intake.
• Patients with known or suspected gastrointestinal obstruction or
lack of motility.
• Patients with known active inflammatory bowel disease.
• Patients when nausea, vomiting or abdominal pain are present.
• Patients with known hypersensitivity to active ingredients or any
of the excipient.
WARNING
Serious electrolyte disturbances (hypernatremia, hypokalemia,
hyperphosphatemia, hypocalcemia)
dehydration, metabolic acidosis, renal failure, tetany and death have
been attributed to physicians prescribing
more than 45 ml dose (usually a minimum of 90 ml during a 24-hour
period) as a bowel preparation for
colonoscopy, surgery or barium enema and/or prescribing it for people
at medical risk.
PRECAUTIONS
Phospho-soda should be used with extreme caution in the elderly, i
                                
                                Đọc toàn bộ tài liệu
                                
                            

Tìm kiếm thông báo liên quan đến sản phẩm này

Xem lịch sử tài liệu